We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
I Agree
Email registered. Please sign in.×
Enter your contact to build trust with supplier(s)×
One More Step to Finalize Your Registration
An activation link has been sent to your email address.
Please check the email and activate your account now. It might take few minutes to get the email.
If you did not find it, please check your spam box.
Having problem receiving the email? Send again
Still cannot receive? Contact us
Email :PharmaSources@imsinoexpo.com
Whatsapp :+86-13621645194
Chengdu Likai Chiral Tech Co., Ltd. (LKChiral), founded in 1997, is envolved from the Pilot production base of Chengdu Institute of Organic Chemistry, the Chinese Academy of Sciences and merged with the Key Laboratory of Asymmetric Synthesis and Chirotechnology of Sichuan Province (KLASC). We owned reputable academic background and accumulates much experiences in the development of chirotechnologies and asymmetric synthesis.
With the strength in the R&D and the much experience in rapid transfer from the technology to the commercial production, LKChiral is committed to the custom manufacture of chiral reagents, chiral fine chemicals, pharmaceutical intermediates and chiral APIs, and also good at custom synthesis and chirotechnology development.In 2005, LKChiral obtained the certificate of ISO9001 and 14001 and with the effective application of the Quality Management Systems, LKChiral has developed one of the famous chiral chemical manufacturers in China.
LKChiral takes a lead role in the chiral chemistry and owns a national platform for the development of chirotechnology, National Engineering Research Center of Chiral Drugs, which is supported by the National Development and Reform Commission of China. There are about 100 researchers and graduate students working or studying in the center and over 50 patents and 200 scientific papers already published.